BRAT1 deficiency causes increased glucose metabolism and mitochondrial malfunction

BMC Cancer

Toru Ouchi¹  Eui Young So¹ 

[1]Department of Cancer Genetics, Roswell Park Cancer Institute, Elm and Carlton Streets, 14263 Buffalo, NY, USA

关键词: ROS;    Mitochondria;    Glucose metabolism;    BRAT1;   

Others  :  1125278
DOI  :  10.1186/1471-2407-14-548

 received in 2014-06-03, accepted in 2014-07-14,  发布年份 2014

【 摘 要 】

Background

BRAT1 (BRCA1-associated ATM activator 1) interacts with both BRCA1, ATM and DNA-PKcs, and has been implicated in DNA damage responses. However, based on our previous results, it has been shown that BRAT1 may be involved in cell growth and apoptosis, besides DNA damage responses, implying that there are undiscovered functions for BRAT1.

Methods

Using RNA interference against human BRAT1, we generated stable BRAT1 knockdown cancer cell lines of U2OS, Hela, and MDA-MA-231. We tested cell growth properties and in vitro/in vivo tumorigenic potentials of BRAT1 knockdown cells compared to control cells. To test if loss of BRAT1 induces metabolic abnormalities, we examined the rate of glycolysis, ATP production, and PDH activity in both BRAT1 knockdown and control cells. The role of BRAT1 in growth signaling was determined by the activation of Akt/Erk, and SC79, Akt activator was used for validation.

Results

By taking advantage of BRAT1 knockdown cancer cell lines, we found that loss of BRAT1 expression significantly decreases cell proliferation and tumorigenecity both in vitro and in vivo. Cell migration was also remarkably lowered when BRAT1 was depleted. Interestingly, glucose uptake and production of mitochondrial ROS (reactive oxygen species) are highly increased in BRAT1 knockdown HeLa cells. Furthermore, both basal and induced activity of Akt and Erk kinases were suppressed in these cells, implicating abnormality in signaling cascades for cellular growth. Consequently, treatment of BRAT1 knockdown cells with Akt activator can improve their proliferation and reduces mitochondrial ROS concentration.

Conclusions

These findings suggest novel roles of BRAT1 in cell proliferation and mitochondrial functions.

【 授权许可】

   
2014 So and Ouchi; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Aglipay JA, Martin SA, Tawara H, Lee SW, Ouchi T: ATM activation by ionizing radiation requires BRCA1-associated BAAT1. J Biol Chem 2006, 281:9710-9718.
• [2]Jackson SP, Bartek J: The DNA-damage response in human biology and disease. Nature 2009, 461:1071-1078.
• [3]So EY, Ouchi T: Functional interaction of BRCA1/ATM-associated BAAT1 with the DNA-PK catalytic subunit. Exp Ther Med 2011, 2:443-447.
• [4]Ouchi M, Ouchi T: Regulation of ATM/DNA-PKcs Phosphorylation by BRCA1-Associated BAAT1. Genes Cancer 2010, 1:1211-1214.
• [5]Puffenberger EG, Jinks RN, Sougnez C, Cibulskis K, Willert RA, Achilly NP, Cassidy RP, Fiorentini CJ, Heiken KF, Lawrence JJ, Mahoney MH, Miller CJ, Nair DT, Politi KA, Worcester KN, Setton RA, Dipiazza R, Sherman EA, Eastman JT, Francklyn C, Robey-Bond S, Rider NL, Gabriel S, Morton DH, Strauss KA: Genetic mapping and exome sequencing identify variants associated with five novel diseases. PLoS One 2012, 7:e28936.
• [6]Saunders CJ, Miller NA, Soden SE, Dinwiddie DL, Noll A, Alnadi NA, Andraws N, Patterson ML, Krivohlavek LA, Fellis J, Humphra S, Saffrey P, Kingsbury Z, Weir JC, Betley J, Grocock RJ, Margulies EH, Farrow EG, Artman M, Safina NP, Petrikin JE, Hall KP, Kingsmore SF: Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci Transl Med 2012, 4:154ra135.
• [7]Pecqueur C, Oliver L, Oizel K, Lalier L, Vallette FM: Targeting metabolism to induce cell death in cancer cells and cancer stem cells. Int J Cell Biol 2013, 2013:805975.
• [8]Wang C, Youle RJ: The role of mitochondria in apoptosis*. Annu Rev Genet 2009, 43:95-118.
• [9]Green DR, Kroemer G: The pathophysiology of mitochondrial cell death. Science 2004, 305:626-629.
• [10]Malik F, Kumar A, Bhushan S, Khan S, Bhatia A, Suri KA, Qazi GN, Singh J: Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine. Apoptosis 2007, 12:2115-2133.
• [11]Meng L, Sefah K, O'Donoghue MB, Zhu G, Shangguan D, Noorali A, Chen Y, Zhou L, Tan W: Silencing of PTK7 in colon cancer cells: caspase-10-dependent apoptosis via mitochondrial pathway. PLoS One 2010, 5:e14018.
• [12]Park KR, Nam D, Yun HM, Lee SG, Jang HJ, Sethi G, Cho SK, Ahn KS: beta-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation. Cancer Lett 2011, 312:178-188.
• [13]Warburg O: On the origin of cancer cells. Science 1956, 123:309-314.
• [14]Warburg O: On respiratory impairment in cancer cells. Science 1956, 124:269-270.
• [15]Pelicano H, Xu RH, Du M, Feng L, Sasaki R, Carew JS, Hu Y, Ramdas L, Hu L, Keating MJ, Zhang W, Plunkett W, Huang P: Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism. J Cell Biol 2006, 175:913-923.
• [16]Pelicano H, Martin DS, Xu RH, Huang P: Glycolysis inhibition for anticancer treatment. Oncogene 2006, 25:4633-4646.
• [17]So EY, Ouchi T: The Potential Role of BRCA1-Associated ATM Activator-1(BRAT1) in Regulation of mTOR. J Cancer Biol Res 2013, 1:3.
• [18]Ongusaha PP, Ouchi T, Kim KT, Nytko E, Kwak JC, Duda RB, Deng CX, Lee SW: BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest. Oncogene 2003, 22:3749-3758.
• [19]Brunner N, Boysen B, Romer J, Spang-Thomsen M: The nude mouse as an in vivo model for human breast cancer invasion and metastasis. Breast Cancer Res Treat 1993, 24:257-264.
• [20]Yang X, Welch DR, Phillips KK, Weissman BE, Wei LL: KAI1, a putative marker for metastatic potential in human breast cancer. Cancer Lett 1997, 119:149-155.
• [21]DeSalvo J, Kuznetsov JN, Du J, Leclerc GM, Leclerc GJ, Lampidis TJ, Barredo JC: Inhibition of Akt potentiates 2-DG-induced apoptosis via downregulation of UPR in acute lymphoblastic leukemia. Mol Cancer Res 2012, 10:969-978.
• [22]Chen W, Gueron M: The inhibition of bovine heart hexokinase by 2-deoxy-D-glucose-6-phosphate: characterization by 31P NMR and metabolic implications. Biochimie 1992, 74:867-873.
• [23]Kurtoglu M, Gao N, Shang J, Maher JC, Lehrman MA, Wangpaichitr M, Savaraj N, Lane AN, Lampidis TJ: Under normoxia, 2-deoxy-D-glucose elicits cell death in select tumor types not by inhibition of glycolysis but by interfering with N-linked glycosylation. Mol Cancer Ther 2007, 6:3049-3058.
• [24]Ambrose M, Goldstine JV, Gatti RA: Intrinsic mitochondrial dysfunction in ATM-deficient lymphoblastoid cells. Hum Mol Genet 2007, 16:2154-2164.
• [25]Valentin-Vega YA, Maclean KH, Tait-Mulder J, Milasta S, Steeves M, Dorsey FC, Cleveland JL, Green DR, Kastan MB: Mitochondrial dysfunction in ataxia-telangiectasia. Blood 2012, 119:1490-1500.
• [26]Frazier AE, Kiu C, Stojanovski D, Hoogenraad NJ, Ryan MT: Mitochondrial morphology and distribution in mammalian cells. Biol Chem 2006, 387:1551-1558.
• [27]Stacpoole PW, Owen R, Flotte TR: The pyruvate dehydrogenase complex as a target for gene therapy. Curr Gene Ther 2003, 3:239-245.
• [28]Shadel GS: Expression and maintenance of mitochondrial DNA: new insights into human disease pathology. Am J Pathol 2008, 172:1445-1456.
• [29]Manning BD, Cantley LC: AKT/PKB signaling: navigating downstream. Cell 2007, 129:1261-1274.
• [30]Wortzel I, Seger R: The ERK cascade: distinct functions within various subcellular organelles. Genes Cancer 2011, 2:195-209.
• [31]Elstrom RL, Bauer DE, Buzzai M, Karnauskas R, Harris MH, Plas DR, Zhuang H, Cinalli RM, Alavi A, Rudin CM, Thompson CB: Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 2004, 64:3892-3899.
• [32]Guha M, Fang JK, Monks R, Birnbaum MJ, Avadhani NG: Activation of Akt is essential for the propagation of mitochondrial respiratory stress signaling and activation of the transcriptional coactivator heterogeneous ribonucleoprotein A2. Mol Biol Cell 2010, 21:3578-3589.
• [33]Chun SY, Johnson C, Washburn JG, Cruz-Correa MR, Dang DT, Dang LH: Oncogenic KRAS modulates mitochondrial metabolism in human colon cancer cells by inducing HIF-1alpha and HIF-2alpha target genes. Mol Cancer 2010, 9:293.
• [34]Uchiumi T, Ohgaki K, Yagi M, Aoki Y, Sakai A, Matsumoto S, Kang D: ERAL1 is associated with mitochondrial ribosome and elimination of ERAL1 leads to mitochondrial dysfunction and growth retardation. Nucleic Acids Res 2010, 38:5554-5568.
• [35]Jo H, Mondal S, Tan D, Nagata E, Takizawa S, Sharma AK, Hou Q, Shanmugasundaram K, Prasad A, Tung JK, Tejeda AO, Man H, Rigby AC, Luo HR: Small molecule-induced cytosolic activation of protein kinase Akt rescues ischemia-elicited neuronal death. Proc Natl Acad Sci U S A 2012, 109:10581-10586.
• [36]Guha M, Srinivasan S, Biswas G, Avadhani NG: Activation of a novel calcineurin-mediated insulin-like growth factor-1 receptor pathway, altered metabolism, and tumor cell invasion in cells subjected to mitochondrial respiratory stress. J Biol Chem 2007, 282:14536-14546.
• [37]Zheng J: Energy metabolism of cancer: glycolysis versus oxidative phosphorylation (Review). Oncol Lett 2012, 4:1151-1157.
• [38]Lu CW, Lin SC, Chen KF, Lai YY, Tsai SJ: Induction of pyruvate dehydrogenase kinase-3 by hypoxia-inducible factor-1 promotes metabolic switch and drug resistance. J Biol Chem 2008, 283:28106-28114.
• [39]Rasheed N, Wang X, Niu QT, Yeh J, Li B: Atm-deficient mice: an osteoporosis model with defective osteoblast differentiation and increased osteoclastogenesis. Hum Mol Genet 2006, 15:1938-1948.
• [40]Kim J, Hwangbo J, Wong PK: p38 MAPK-Mediated Bmi-1 down-regulation and defective proliferation in ATM-deficient neural stem cells can be restored by Akt activation. PLoS One 2011, 6:e16615.